Lower margin of Ranbaxy is an opportunity: Sun Pharma

  • 10:33
  • Published On: April 09, 2014
Cinema View
Embed
Speaking to NDTV Profit, Sun Pharma chairman Israel Makov said the acquisition would be an opportunity to increase Ranbaxy's margin.

Related Videos

Sun Pharma Q4 Profit In Line With Estimates
May 26, 2023 0:35
Drug Major Sun Pharma Hit By Ransomware Attack
March 27, 2023 1:53
Exclusive: The Cash-For-'Bail' Tapes
December 16, 2021 13:46
To Get Bail, Jailed Tycoon's Family Pay Crores To Conman
December 16, 2021 3:22
The Sukesh Chandrashekhar-Shivinder Family Tapes
December 16, 2021 3:43
Conman Calls Tycoon's Wife, Poses As Union Home Secretary
December 16, 2021 3:10
"Amazed That A Person Like Shivinder Singh Would Fall Into A Trap": Ex IPS Officer On Cash-For-Bail Scam
December 16, 2021 0:56
From Jail Cell, Conman Operates 'Cash-For-Bail' Scam
December 16, 2021 1:33
The Biggest Stories Of December 16, 2021
December 16, 2021 17:00
Top News Of The Day: Cash For Bail - How Conman Sukesh Chandrashekhar Gypped Tycoon's Wife
December 16, 2021 23:48
Exclusive: The Cash-for-'Bail' Tapes - A Jailed Tycoon, His Wife And A Conman
December 16, 2021 23:03
Exclusive: Cash-For-'Bail' Tapes - Jailed Tycoon, His Wife And A Crook
December 16, 2021 13:44
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination